biliary carcinoma
Showing 1 - 8 of 8
Biliary Carcinoma Trial in Qingdao (TQB3454 tablets)
Not yet recruiting
- Biliary Carcinoma
- TQB3454 tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Nov 15, 2023
Biliary Carcinoma Trial in China (TQB3454 tablets, TQB3454 tablets matching )
Not yet recruiting
- Biliary Carcinoma
- TQB3454 tablets
- TQB3454 tablets matching placebo
-
Beijing, Beijing, China
- +5 more
Aug 4, 2023
Biliary Carcinoma Trial in Nanjing (Disitamab Vedotin combined with Zimberelizumab)
Recruiting
- Biliary Carcinoma
- Disitamab Vedotin combined with Zimberelizumab
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Sep 14, 2022
Biliary Carcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Trial in Tampa (Cisplatin, Gemcitabine, Copanlisib)
Completed
- Biliary Carcinoma
- +3 more
- Cisplatin
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 3, 2021
Biliary Carcinoma Trial in Nanning (Capecitabine, Apatinib)
Unknown status
- Biliary Carcinoma
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 7, 2018
Biliary Carcinoma Trial in Italy (Panitumumab plus GEMOX chemo, GEMOX chemo)
Completed
- Biliary Carcinoma
- Panitumumab plus GEMOX chemotherapy
- GEMOX chemotherapy
-
Aviano, Pordenone, Italy
- +11 more
May 27, 2015